Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • The kids aren’t alright: How Generation Covid is losing out | Free to read
    • Comfortable in court: Donald Trump reprises playbook for election fight
    • UK’s Brexit negotiator predicted Brussels would have upper hand
    • Lawsuit tracker: Trump’s battle faces tough test this week
    • UK prepares to make ‘big bet’ on hydrogen power
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Johnson seeks Downing St reset with ‘green industrial revolution’
    • Hopes grow for post-Brexit trade deal next week
    • Watchdog criticises government over awarding of £17bn Covid contracts
    • Andrew Bailey signals looser UK financial regulations in investment drive
    • On the ground with UK efforts to train drivers for post-Brexit border
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Taylor Swift’s catalogue sold to private equity group for $300m
    • Warren Buffett pulls back on banks and bets on drugmakers
    • Amazon launches online pharmacy in challenge to traditional retailers
    • Global M&A recovers on vaccine hopes and US political stability
    • FTI Consulting faces client backlash over oil industry work
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Hedge funds under scrutiny over role in March bond market ructions
    • Bank regulator calls for dividends to remain on hold
    • Zambia’s debt crisis casts a long, global shadow
    • Saudi Aramco to sell billions of dollars in international bonds
    • US stocks hit new record after Moderna vaccine data
  • Climate
  • Graphics
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Work & Careers
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why inflation could be on the way back
    • Boris Johnson: Now is the time to plan our green recovery
    • Without Trump to loathe, US Democrats face troublesome splits
    • Biden’s flawed plan for global leadership
    • Three ways the banks will be winners from Covid recovery
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Best Books of the Year 2020
    • Best books of 2020: Economics
    • Erdogan’s family drama and the future of Turkey
    • Best books of 2020: Business
    • ‘Glimmers of good living’: the FT’s London lockdown discoveries
  • How to Spend It
  • Sign In
  • Subscribe
  1. Markets
  2. Equities
  • US Equities
  • UK Equities
  • European Equities
  • Asia-Pacific Equities
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Graphics
  • Opinion
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

$50 for your first 3 months Get the print edition and steer from crisis to recovery

Subscribe now

Equities

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Wednesday, 18 November, 2020
    Markets Briefing
    Vaccine-led rally puts European stocks on course for record month

    Stoxx 600 and Xetra Dax advance as latest Pfizer and BioNTech news provides cheer

    2 hours ago
  • Wednesday, 18 November, 2020
    AnalysisFT Alphaville
    Morgan Stanley go all in on Tesla

    “It’s expensive on what we know, and cheap on what we don’t.”

    2 hours ago
  • Wednesday, 18 November, 2020
    ETF HubThe latest news on ETFs
    Multi-factor funds fall out of favour after poor performance

    Closures outstrip launches for the first time in nearly two decades

  • Wednesday, 18 November, 2020
    Coronavirus pandemic
    China pharma shares fall as western rivals lead in vaccine trials

    Groups including CanSino look to developing markets to gain edge

  • Wednesday, 18 November, 2020
    Markets InsightMichael Mauboussin
    Why value investing still works in markets

    To buy something for less than it is worth is as useful as ever

  • Tuesday, 17 November, 2020
    Emerging markets
    Investors bet vaccine-led recovery will lift emerging markets

    EM equities and currencies cited as favourite trades in monthly survey

  • Tuesday, 17 November, 2020
    Markets Briefing
    Wall Street stocks slip over weak US consumer data

    Equity markets in Europe also decline as lockdowns weigh on investor sentiment

  • Tuesday, 17 November, 2020
    LexTesla Inc
    Tesla/S&P 500: Musk-have purchase Premium

    Group’s admission will cause ruckus that low-profile index compilers may prefer to avoid

  • Tuesday, 17 November, 2020
    ETF HubThe latest news on ETFs
    Vanguard and BlackRock tighten stranglehold on ETF industry

    Dominant duo power ahead as allure of active equity managers fades

  • Promoted Content
  • Tuesday, 17 November, 2020
    Equity valuation
    Historic vaccine boost for value stocks sparks debate on market reset

    ‘Astounding’ switch into unloved industries breaks records

  • Tuesday, 17 November, 2020
    Berkshire Hathaway Inc
    Buffett pulls back on banks and bets on drugmakers

    Billionaire investor’s Berkshire Hathaway put $5.7bn into four US pharma stocks in Q3

  • Tuesday, 17 November, 2020
    Tesla Inc
    Tesla to join S&P 500 in December

    Elon Musk’s electric carmaker may be too big to add all in one go, index provider says

  • Monday, 16 November, 2020
    Markets Briefing
    US stocks hit new record after Moderna vaccine data

    Eyeing path to pandemic’s end, investors chase travel, energy and financial stocks higher

  • Monday, 16 November, 2020
    Trading technology
    Australia bourse apologises for shutdown after software glitch

    ASX says problem will be resolved in time for trading to resume on Tuesday

  • Sunday, 15 November, 2020
    ExplainerMarket Questions
    Will Turkey’s new central bank governor announce a big rate rise?

    Market Questions is the FT’s guide to the week ahead

  • Saturday, 14 November, 2020
    Fund management
    Inflows into stock funds hit 20-year high

    Firepower boosts equity markets on back of Covid-19 vaccine breakthrough

  • Saturday, 14 November, 2020
    Analysis
    Stock market investors start to look beyond coronavirus

    Strategists say uncertainty has reduced, but lockdowns complicate the picture

  • Saturday, 14 November, 2020
    Hedge funds
    Hedge funds hit after abrupt market pivot on vaccine

    Breakthrough in fight against Covid-19 caused ‘unprecedented’ rotation in stocks

  • Saturday, 14 November, 2020
    The Long ViewMichael Mackenzie
    A rotation in equity markets starts to emerge

    Covid-19 vaccine breakthrough prompts shift in investor portfolios towards cyclical companies

  • Friday, 13 November, 2020
    Markets Briefing
    US stocks set new record as investors look to Covid vaccine

    Optimism for dealing with pandemic next year trumps rising infection numbers

  • Friday, 13 November, 2020
    Chinese business & finance
    British ‘hong’ Swire drops out of Hong Kong’s stock index

    Colonial era conglomerate’s replacement by Chinese delivery app marks shift to mainland

  • Friday, 13 November, 2020
    Coronavirus economic impact
    UK companies restore dividends after taking furlough cash

    Businesses return £400m to government but others keep support money despite making investor payouts

  • Friday, 13 November, 2020
    Chinese equities
    US ban on China military-linked stocks creates investor woe

    Trump executive order poses compliance challenge for fund managers

  • Friday, 13 November, 2020
    The Top LineTom Braithwaite
    Executives have no excuse for dumping stock

    Pfizer chief’s explanation for selling $5.6m of shares on the day of the vaccine news does not wash

  • Friday, 13 November, 2020
    AnalysisMergers & Acquisitions
    The Spac sponsor bonanza

    FT analysis shows backers of cash shells earn billions in what Ackman calls ‘one of the greatest gigs’

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubMBA Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2020. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

  • Switch to International Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Graphics
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Work & Careers
    • Lex
    • Obituaries
    • Letters
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In